Brought to you by 
Vaccine maker Juvaris gets $6mm from Series A; adds $6mm
Jan 2007
Executive Summary
Juvaris BioTherapeutics (cancer and infectious disease vaccines) raised $6mm from Kleiner Perkins Caufield & Byers Pandemic & Biodefense Fund in the first tranche of its Series A financing. Within the next four months, the company hopes to gross another $6mm to bring the Series A total to $12mm.
Deal Industry
-
Biotechnology
- Large Molecule
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Vaccine maker Juvaris gets $6mm from Series A; adds $6mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice